help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raval-Pandya, M.
Right arrow Articles by Christakos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raval-Pandya, M.
Right arrow Articles by Christakos, S.
Molecular Endocrinology 15 (6): 1035-1046
Copyright © 2001 by The Endocrine Society

YY1 Represses Vitamin D Receptor-Mediated 25-Hydroxyvitamin D3 24-Hydroxylase Transcription: Relief of Repression by CREB-Binding Protein

Mihali Raval-Pandya, Puneet Dhawan, Frank Barletta and Sylvia Christakos

Department of Biochemistry and Molecular Biology University of Medicine and Dentistry of New Jersey-New Jersey Medical School Newark, New Jersey 07103

Ying Yang transcription factor (YY1) can repress or activate transcription. 25-Hydroxyvitamin D3-24-hydroxylase [24(OH)ase], an enzyme involved in the catabolism of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], is up-regulated at the transcriptional level by 1,25-(OH)2D3 to self-induce its deactivation. Here we report that YY1 can repress 1,25-(OH)2D3-induced 24(OH)ase transcription in CV1 cells transfected with vitamin D receptor (VDR) expression vector or in LLCPK1 cells that contain VDR endogenously. With increasing amounts of YY1 DNA transfected (500 ng to 2 µg), ligand-dependent VDR activation of 24(OH)ase transcription was steadily repressed (maximum repression was 10-fold). Thus, YY1 may be a key modulator preventing activation at times that do not require the enzyme to be expressed. Relief of YY1 repression was observed in the presence of TFIIB or CBP (CREB binding protein) suggesting that YY1 may exert repression, in part, by sequestering TFIIB/CBP. Glutathione-S-transferase (GST) pull-down assays identified regions in the N and C termini of CBP that can bind YY1. In addition, the N-terminal region of CBP that interacts with YY1 can inhibit YY1 from binding to TFIIB. Thus, CBP may alleviate YY1-mediated repression, in part, by preventing YY1 from binding to TFIIB, which is required for VDR-mediated transcription. In summary, our results suggest that YY1 represses 24(OH)ase transcription, at least in part, by sequestering activator proteins involved in VDR-mediated transcription. In addition, our findings demonstrate a role for CBP in relief of repression of VDR-mediated transcription.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Bikle
Nonclassic Actions of Vitamin D
J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 26 - 34.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Liu, K. A. Merkler, X. Zhang, and M. P. McLean
Prostaglandin F2{alpha} Suppresses Rat Steroidogenic Acute Regulatory Protein Expression via Induction of Yin Yang 1 Protein and Recruitment of Histone Deacetylase 1 Protein
Endocrinology, November 1, 2007; 148(11): 5209 - 5219.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M. Banwell, D. P. MacCartney, M. Guy, A. E. Miles, M. R. Uskokovic, J. Mansi, P. M. Stewart, L. P. O'Neill, B. M. Turner, K. W. Colston, et al.
Altered nuclear receptor corepressor expression attenuates vitamin d receptor signaling in breast cancer cells.
Clin. Cancer Res., April 1, 2006; 12(7): 2004 - 2013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Y. Begon, L. Delacroix, D. Vernimmen, P. Jackers, and R. Winkler
Yin Yang 1 Cooperates with Activator Protein 2 to Stimulate ERBB2 Gene Expression in Mammary Cancer Cells
J. Biol. Chem., July 1, 2005; 280(26): 24428 - 24434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Imamura, C. Imamura, Y. Iwamoto, and L. J. Sandell
Transcriptional Co-activators CREB-binding Protein/p300 Increase Chondrocyte Cd-rap Gene Expression by Multiple Mechanisms Including Sequestration of the Repressor CCAAT/Enhancer-binding Protein
J. Biol. Chem., April 29, 2005; 280(17): 16625 - 16634.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Dhawan, X. Peng, A. L. M. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy, and S. Christakos
Functional Cooperation between CCAAT/Enhancer-Binding Proteins and the Vitamin D Receptor in Regulation of 25-Hydroxyvitamin D3 24-Hydroxylase
Mol. Cell. Biol., January 1, 2005; 25(1): 472 - 487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Barletta, P. Dhawan, and S. Christakos
Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E598 - E608.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin, H. Ishizuka, E. Kharasch, J. Schuetz, and E. Schuetz
Transcriptional Control of Intestinal Cytochrome P-4503A by 1alpha ,25-Dihydroxy Vitamin D3
Mol. Pharmacol., December 1, 2001; 60(6): 1399 - 1406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society